Surgical Science Sweden AB (publ) (FRA:4P41)

FRA:4P41 Statistics

Total Valuation

FRA:4P41 has a market cap or net worth of EUR 157.21 million. The enterprise value is 99.64 million.

Market Cap	157.21M
Enterprise Value	99.64M

Important Dates

The last earnings date was Thursday, February 19, 2026.

Earnings Date	Feb 19, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	51.03M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	43.09M

Valuation Ratios

The trailing PE ratio is 25.46 and the forward PE ratio is 14.66.

PE Ratio	25.46
Forward PE	14.66
PS Ratio	1.71
PB Ratio	0.40
P/TBV Ratio	1.90
P/FCF Ratio	24.98
P/OCF Ratio	21.32
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.88, with an EV/FCF ratio of 15.83.

EV / Earnings	16.14
EV / Sales	1.07
EV / EBITDA	4.88
EV / EBIT	7.91
EV / FCF	15.83

Financial Position

The company has a current ratio of 4.07, with a Debt / Equity ratio of 0.00.

Current Ratio	4.07
Quick Ratio	2.83
Debt / Equity	0.00
Debt / EBITDA	0.01
Debt / FCF	0.02
Interest Coverage	21.69

Financial Efficiency

Return on equity (ROE) is 1.47% and return on invested capital (ROIC) is 2.44%.

Return on Equity (ROE)	1.47%
Return on Assets (ROA)	1.65%
Return on Invested Capital (ROIC)	2.44%
Return on Capital Employed (ROCE)	3.06%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	292,957
Profits Per Employee	19,726
Employee Count	328
Asset Turnover	0.20
Inventory Turnover	1.74

Taxes

In the past 12 months, FRA:4P41 has paid 3.08 million in taxes.

Income Tax	3.08M
Effective Tax Rate	33.27%

Stock Price Statistics

The stock price has decreased by -78.72% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-78.72%
50-Day Moving Average	2.73
200-Day Moving Average	8.49
Relative Strength Index (RSI)	67.46
Average Volume (20 Days)	21

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:4P41 had revenue of EUR 91.70 million and earned 6.17 million in profits. Earnings per share was 0.12.

Revenue	91.70M
Gross Profit	60.77M
Operating Income	12.43M
Pretax Income	9.25M
Net Income	6.17M
EBITDA	17.99M
EBIT	12.43M
Earnings Per Share (EPS)	0.12

Balance Sheet

The company has 56.96 million in cash and 150,155 in debt, with a net cash position of 56.81 million.

Cash & Cash Equivalents	56.96M
Total Debt	150,155
Net Cash	56.81M
Net Cash Per Share	n/a
Equity (Book Value)	394.84M
Book Value Per Share	7.74
Working Capital	82.57M

Cash Flow

In the last 12 months, operating cash flow was 7.37 million and capital expenditures -1.08 million, giving a free cash flow of 6.29 million.

Operating Cash Flow	7.37M
Capital Expenditures	-1.08M
Free Cash Flow	6.29M
FCF Per Share	n/a

Margins

Gross margin is 66.28%, with operating and profit margins of 13.55% and 6.73%.

Gross Margin	66.28%
Operating Margin	13.55%
Pretax Margin	10.09%
Profit Margin	6.73%
EBITDA Margin	19.62%
EBIT Margin	13.55%
FCF Margin	6.86%

Dividends & Yields

FRA:4P41 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	3.93%
FCF Yield	4.00%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:4P41 has an Altman Z-Score of 9.53 and a Piotroski F-Score of 6.

Altman Z-Score	9.53
Piotroski F-Score	6